Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

How a Medicinal Chemistry Project Changed the Way Prostate Cancer is Diagnosed and Treated.

How a Medicinal Chemistry Project Changed the Way Prostate Cancer is Diagnosed and Treated.

Journal: Journal of medicinal chemistry
Published: October 06, 2025

Radionuclides Landscape in Prostate Cancer Theranostics.

Radionuclides Landscape in Prostate Cancer Theranostics.

Journal: International journal of molecular sciences
Published: June 17, 2025

Revolutionizing Prostate Cancer Detection: The Role of Approved PSMA-PET Imaging Agents.

Revolutionizing Prostate Cancer Detection: The Role of Approved PSMA-PET Imaging Agents.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 19, 2025

Different Appearances of Esophageal Squamous Cell Carcinoma in 18F-PSMA PET/CT Versus 18F-FDG PET/CT.

Different Appearances of Esophageal Squamous Cell Carcinoma in 18F-PSMA PET/CT Versus 18F-FDG PET/CT.

Journal: Clinical nuclear medicine
Published: October 30, 2024

Clinical Factors Associated With Suspicious 18F-DCFPyL PSMA PET Activity in Patients Initially Managed With Radical Prostatectomy Including Prostate-Specific Antigen < 0.5 ng/mL.

Clinical Factors Associated With Suspicious 18F-DCFPyL PSMA PET Activity in Patients Initially Managed With Radical Prostatectomy Including Prostate-Specific Antigen < 0.5 ng/mL.

Journal: The Journal of urology
Published: October 18, 2024

Impact of Baseline Renal Insufficiency on Piflufolastat F-18 Performance and Investigation of Changes in Renal Function Following Piflufolastat F-18 Administration: Results From the OSPREY Trial.

Impact of Baseline Renal Insufficiency on Piflufolastat F-18 Performance and Investigation of Changes in Renal Function Following Piflufolastat F-18 Administration: Results From the OSPREY Trial.

Journal: Clinical genitourinary cancer
Published: June 10, 2024

Evaluation of online teaching modules for PSMA PET interpretation.

Evaluation of online teaching modules for PSMA PET interpretation.

Journal: The Prostate
Published: March 14, 2024

Prostate-Specific Membrane Antigen PET/CT Detection of Prostate Cancer Metastasis to Thyroid and Cricoid Cartilages.

Prostate-Specific Membrane Antigen PET/CT Detection of Prostate Cancer Metastasis to Thyroid and Cricoid Cartilages.

Journal: Clinical nuclear medicine
Published: February 23, 2024

PSMA-targeted radiotheranostics in modern nuclear medicine: then, now, and what of the future?

PSMA-targeted radiotheranostics in modern nuclear medicine: then, now, and what of the future?

Journal: Theranostics
Published: November 26, 2023

An Expedition on Synthetic Methodology of FDA-approved Anticancer Drugs (2018-2021).

An Expedition on Synthetic Methodology of FDA-approved Anticancer Drugs (2018-2021).

Journal: Anti-cancer agents in medicinal chemistry
Published: August 16, 2023

Comparison of Multiple Segmentation Methods for Volumetric Delineation of Primary Prostate Cancer with Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL PET/CT.

Comparison of Multiple Segmentation Methods for Volumetric Delineation of Primary Prostate Cancer with Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL PET/CT.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: May 10, 2023

Impact of piflufolastat F-18 PSMA PET imaging on clinical decision-making in prostate cancer across disease states: A retrospective review.

Impact of piflufolastat F-18 PSMA PET imaging on clinical decision-making in prostate cancer across disease states: A retrospective review.

Journal: The Prostate
Published: January 20, 2023
Showing 1-12 of 18

Last Updated: 10/31/2025